• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Azodyl to target uremic toxins, reduce azotemia associated with chronic kidney disease

July 1, 2006

Buena, N.J. - This month, Azodyl? becomes available exclusively to veterinarians to target uremic toxins and reduces azotemia in dogs and cats with chronic kidney disease (CKD).

BUENA, N.J. — This month, Azodyl™ becomes available exclusively to veterinarians to target uremic toxins and reduces azotemia in dogs and cats with chronic kidney disease (CKD).

Vétoquinol will market the new nutritional supplement which is manufactured by Kibow Biotech.

Dr. Eric Linn, director of scientific services for Vétoquinol USA, says that the product is the first of its kind and designed to help veterinarians improve the quality of life of pets suffering from CKD.

"We are going to improve the quantity and quality of life for these guys," Linn says at last month's American College of Veterinary Internal Medicine meeting in Louisville, Ky.

Advertisement

Additional benefits are expected for pets that develop acute renal failure, which can lead to CKD, he says.

Azodyl contains three beneficial bacteria: Enterococcus thermophilus, Bifidobacterium longum and Lactobacillus acidophilus. These bacteria target and metabolize uremic toxins in the bowel and are then excreted, he says, noting that high levels of uremic toxins in blood correspond with uremic toxins in the bowel.

It's called Enteric Dialysis®. "Azodyl supports the kidneys by working in the bowel," Linn explains. "It represents a breakthrough treatment in the management of azotemia in pets."

Azodyl's enteric-coated capsules protect the beneficial bacteria from digestive tract acids until they get to the bowel, where they dissolve. The capsules also contain the prebiotic psyllium husk, which aids the proliferation of the bacteria.

Clinical trials with leading veterinary nephrologists are underway and early clinical experience with Azodyl has yielded excellent results. Dr. Richard Palmquist, a California veterinarian who conducted a small independent study, found a "very clear relationship between use of Azodyl and decreasing azotemia" and patients experienced "improved health and vitality."

For pets with kidney failure, Azodyl can be administered in pet food or in a treat such as peanut butter. The number of capsules required daily range from one for dogs and cats under 5 pounds to three capsules given twice daily in dogs more than 10 pounds. The capsules must be refrigerated to preserve freshness.

Studies show that Epakitin, which was launched last year, also lowers azotemia, but its primary benefit is decreased phosphatemia, which helps slow the destructive cycle of CKD and increases life expectancy for pets.

Azodyl and Epakitin can be used together and with other CKD treatments such as diet, fluid therapy, ACE inhibitors and treatment of underlying conditions, Linn says.

For fastest response, call

(800) 267-5707

www.vetoquinolusa.com

Related Content:

Products
Zoetis unveils Alphatrak 3 glucose monitoring system for cats and dogs
Zoetis unveils Alphatrak 3 glucose monitoring system for cats and dogs
 Vetstoria releases its Fill Rate platform
Vetstoria releases its Fill Rate platform
Communicating the importance of genetic screening
Communicating the importance of genetic screening

Advertisement

Latest News

Dogs and staff at Seattle dog resort safely escape fire

Pet safety for this Super Bowl Sunday

New video series informs pet owners on dog and cat nutrition

3 Must-reads for National Pet Dental Health Month

View More Latest News
Advertisement